GLOMERULONEPHRITIS, MEMBRANOUS

Clinical trials for GLOMERULONEPHRITIS, MEMBRANOUS explained in plain language.

Never miss a new study

Get alerted when new GLOMERULONEPHRITIS, MEMBRANOUS trials appear

Sign up with your email to follow new studies for GLOMERULONEPHRITIS, MEMBRANOUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Can a single Immune-Targeting drug quiet an autoimmune kidney disease?

Disease control Ongoing

This trial tests whether rituximab, an infusion drug that calms certain immune cells, can help people with idiopathic membranous nephropathy and nephrotic syndrome. Participants receive either rituximab or a placebo, and the study tracks how many achieve a significant reduction i…

Matched conditions: GLOMERULONEPHRITIS, MEMBRANOUS

Phase: PHASE3 • Sponsor: Shoichi Maruyama MD PhD • Aim: Disease control

Last updated Aug 14, 2026 00:00 UTC

GLOMERULONEPHRITIS, MEMBRANOUS

Get alerted when new GLOMERULONEPHRITIS, MEMBRANOUS trials appear

Can a single Immune-Targeting drug quiet an autoimmune kidney disease?